116 related articles for article (PubMed ID: 16781370)
1. Association of paraoxonase-1 activity and concentration with angiographic severity and extent of coronary artery disease.
Granér M; James RW; Kahri J; Nieminen MS; Syvänne M; Taskinen MR
J Am Coll Cardiol; 2006 Jun; 47(12):2429-35. PubMed ID: 16781370
[TBL] [Abstract][Full Text] [Related]
2. Association between paraoxonase-1 activity and lipid peroxidation indicator levels in people living in the Antalya region with angiographically documented coronary artery disease.
Göçmen AY; Gümüşlü S; Semiz E
Clin Cardiol; 2004 Jul; 27(7):426-30. PubMed ID: 15298047
[TBL] [Abstract][Full Text] [Related]
3. Low paraoxonase 1 arylesterase activity and high von Willebrand factor levels are associated with severe coronary atherosclerosis in patients with non-diabetic stable coronary artery disease.
Ding J; Chen Q; Zhuang X; Feng Z; Xu L; Chen F
Med Sci Monit; 2014 Nov; 20():2421-9. PubMed ID: 25420483
[TBL] [Abstract][Full Text] [Related]
4. Improved risk assessment of coronary artery disease by substituting paraoxonase 1 activity for HDL-C: Novel cardiometabolic biomarkers based on HDL functionality.
Mahrooz A; Shokri Y; Variji A; Zargari M; Alizadeh A; Mehtarian E
Nutr Metab Cardiovasc Dis; 2021 Apr; 31(4):1166-1176. PubMed ID: 33579580
[TBL] [Abstract][Full Text] [Related]
5. Novel serum paraoxonase activity assays are associated with coronary artery disease.
Martinelli N; Girelli D; Olivieri O; Guarini P; Bassi A; Trabetti E; Friso S; Pizzolo F; Bozzini C; Tenuti I; Annarumma L; Schiavon R; Franco Pignatti P; Corrocher R
Clin Chem Lab Med; 2009; 47(4):432-40. PubMed ID: 19275503
[TBL] [Abstract][Full Text] [Related]
6. Paraoxonase (PON1) activity in north west Indian Punjabis with coronary artery disease & type 2 diabetes mellitus.
Singh S; Venketesh S; Verma JS; Verma M; Lellamma CO; Goel RC
Indian J Med Res; 2007 Jun; 125(6):783-7. PubMed ID: 17704557
[TBL] [Abstract][Full Text] [Related]
7. Paraoxonase 1 gene polymorphisms in angiographically assessed coronary artery disease: evidence for gender interaction among Brazilians.
Rios DL; D'Onofrio LO; Cerqueira CC; Bonfim-Silva R; Carvalho HG; Santos-Filho A; Galvão-Castro B
Clin Chem Lab Med; 2007; 45(7):874-8. PubMed ID: 17617030
[TBL] [Abstract][Full Text] [Related]
8. PON-1 Activity and Plasma 8-Isoprostane Concentration in Patients with Angiographically Proven Coronary Artery Disease.
Kuchta A; Strzelecki A; Ćwiklińska A; Totoń M; Gruchała M; Zdrojewski Z; Kortas-Stempak B; Gliwińska A; Dąbkowski K; Jankowski M
Oxid Med Cell Longev; 2015; 2015():5136937. PubMed ID: 26697134
[TBL] [Abstract][Full Text] [Related]
9. Association of elevated apoA-I glycation and reduced HDL-associated paraoxonase1, 3 activity, and their interaction with angiographic severity of coronary artery disease in patients with type 2 diabetes mellitus.
Shen Y; Ding FH; Sun JT; Pu LJ; Zhang RY; Zhang Q; Chen QJ; Shen WF; Lu L
Cardiovasc Diabetol; 2015 May; 14():52. PubMed ID: 25964115
[TBL] [Abstract][Full Text] [Related]
10. Hyperhomocysteinemia, paraoxonase activity and risk of coronary artery disease.
Kerkeni M; Addad F; Chauffert M; Chuniaud L; Miled A; Trivin F; Maaroufi K
Clin Biochem; 2006 Aug; 39(8):821-5. PubMed ID: 16875684
[TBL] [Abstract][Full Text] [Related]
11. Insulin resistance as predictor of the angiographic severity and extent of coronary artery disease.
Granér M; Syvänne M; Kahri J; Nieminen MS; Taskinen MR
Ann Med; 2007; 39(2):137-44. PubMed ID: 17453676
[TBL] [Abstract][Full Text] [Related]
12. Serum myeloperoxidase/paraoxonase 1 ratio as potential indicator of dysfunctional high-density lipoprotein and risk stratification in coronary artery disease.
Haraguchi Y; Toh R; Hasokawa M; Nakajima H; Honjo T; Otsui K; Mori K; Miyamoto-Sasaki M; Shinohara M; Nishimura K; Ishida T; Hirata K
Atherosclerosis; 2014 Jun; 234(2):288-94. PubMed ID: 24704632
[TBL] [Abstract][Full Text] [Related]
13. Reduced paraoxonase 1 activity as a marker for severe coronary artery disease.
Zhou C; Cao J; Shang L; Tong C; Hu H; Wang H; Fan D; Yu H
Dis Markers; 2013; 35(2):97-103. PubMed ID: 24167353
[TBL] [Abstract][Full Text] [Related]
14. Low serum paraoxonase1 activity levels predict coronary artery disease severity.
Sun T; Hu J; Yin Z; Xu Z; Zhang L; Fan L; Zhuo Y; Wang C
Oncotarget; 2017 Mar; 8(12):19443-19454. PubMed ID: 28038449
[TBL] [Abstract][Full Text] [Related]
15. Serum paraoxonase 1 activity in women with metabolic syndrome.
Yilmaz H; Sayar N; Yilmaz M; Gurkan U; Sesal C; Tosu R; Cakmak N; Erer B; Oz D; Ciloglu F; Bolca O
Kardiol Pol; 2010 Nov; 68(11):1219-24. PubMed ID: 21108196
[TBL] [Abstract][Full Text] [Related]
16. The relationship between paraoxonase1-192 polymorphism and activity with coronary artery disease.
Mohamed RH; Mohamed RH; Karam RA; Abd El-Aziz TA
Clin Biochem; 2010 Apr; 43(6):553-8. PubMed ID: 20026099
[TBL] [Abstract][Full Text] [Related]
17. Determinants of homocysteine-thiolactonase activity of the paraoxonase-1 (PON1) protein in humans.
Lacinski M; Skorupski W; Cieslinski A; Sokolowska J; Trzeciak WH; Jakubowski H
Cell Mol Biol (Noisy-le-grand); 2004 Dec; 50(8):885-93. PubMed ID: 15704252
[TBL] [Abstract][Full Text] [Related]
18. Association of homocysteine thiolactonase activity and PON1 polymorphisms with the severity of acute coronary syndrome.
Koubaa N; Nakbi A; Hammami S; Attia N; Mehri S; Ben Hamda K; Ben Farhat M; Miled A; Hammami M
Clin Biochem; 2009 Jun; 42(9):771-6. PubMed ID: 19269283
[TBL] [Abstract][Full Text] [Related]
19. PON1 activity is inversely related to LDL apoB carbonyl content in patients with coronary artery disease.
Sharma R; Singh B; Mahajan M
Kaohsiung J Med Sci; 2007 May; 23(5):225-31. PubMed ID: 17525004
[TBL] [Abstract][Full Text] [Related]
20. Association between paraoxonase 1 activity and severity of coronary artery disease in patients with acute coronary syndromes.
Sentürk T; Sarandöl E; Güllülü S; Erdinç S; Ozdemir B; Baran I; Aydinlar A
Acta Cardiol; 2008 Jun; 63(3):361-7. PubMed ID: 18664028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
